Literature DB >> 24556397

Chemical biology of antigen presentation by MHC molecules.

Sander I van Kasteren1, Hermen Overkleeft1, Huib Ovaa1, Jacques Neefjes2.   

Abstract

MHC class I and MHC class II molecules present peptides to the immune system to drive proper T cell responses. Pharmacological modulation of T-cell responses can offer treatment options for a range of immune-related diseases. Pharmacological downregulation of MHC molecules may find application in treatment of auto-immunity and transplantation rejection while pharmacological activation of antigen presentation would support immune responses to infection and cancer. Since the cell biology of MHC class I and MHC class II antigen presentation is understood in great detail, many potential targets for manipulation have been defined over the years. Here, we discuss how antigen presentation by MHC molecules can be modulated by pharmacological agents and how chemistry can further support the study of antigen presentation in general. The chemical biology of antigen presentation by MHC molecules shows surprising options for immune modulation and the development of future therapies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24556397     DOI: 10.1016/j.coi.2013.10.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  17 in total

1.  Linarin down-regulates phagocytosis, pro-inflammatory cytokine production, and activation marker expression in RAW264.7 macrophages.

Authors:  Bomi Kim; Jong Hun Lee; Myung-Ji Seo; Seok Hyun Eom; Wooki Kim
Journal:  Food Sci Biotechnol       Date:  2016-10-31       Impact factor: 2.391

2.  Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.

Authors:  Marvin M van Luijn; Karim L Kreft; Marlieke L Jongsma; Steven W Mes; Annet F Wierenga-Wolf; Marjan van Meurs; Marie-José Melief; Rik van der Kant; Lennert Janssen; Hans Janssen; Rusung Tan; John J Priatel; Jacques Neefjes; Jon D Laman; Rogier Q Hintzen
Journal:  Brain       Date:  2015-03-29       Impact factor: 13.501

3.  Gene Expression in Mouse Thyrotrope Adenoma: Transcription Elongation Factor Stimulates Proliferation.

Authors:  Peter Gergics; Helen C Christian; Monica S Choo; Adnan Ajmal; Sally A Camper
Journal:  Endocrinology       Date:  2016-07-19       Impact factor: 4.736

4.  Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.

Authors:  Marvin M van Luijn; Willemijn van den Ancker; S Marieke van Ham; Arjan A van de Loosdrecht
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

5.  The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.

Authors:  Daniela Weiskopf; Michael A Angelo; Derek J Bangs; John Sidney; Sinu Paul; Bjoern Peters; Aruna D de Silva; Janet C Lindow; Sean A Diehl; Stephen Whitehead; Anna Durbin; Beth Kirkpatrick; Alessandro Sette
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 6.  A guide to antigen processing and presentation.

Authors:  Novalia Pishesha; Thibault J Harmand; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2022-04-13       Impact factor: 53.106

7.  Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.

Authors:  Janet Lei; Wolfram Osen; Adriane Gardyan; Agnes Hotz-Wagenblatt; Guochao Wei; Lutz Gissmann; Stefan Eichmüller; Martin Löchelt
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

8.  Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers.

Authors:  Andrzej Wiśniewski; Maciej Sobczyński; Konrad Pawełczyk; Irena Porębska; Monika Jasek; Marta Wagner; Wanda Niepiekło-Miniewska; Aneta Kowal; Joanna Dubis; Natalia Jędruchniewicz; Piotr Kuśnierczyk
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

Review 9.  Posttranslational Modifications and the Immunogenicity of Biotherapeutics.

Authors:  Roy Jefferis
Journal:  J Immunol Res       Date:  2016-04-14       Impact factor: 4.818

10.  Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.

Authors:  Dan Zhao; Laela M Hajiaghamohseni; Xiang Liu; Zdzislaw M Szulc; Aiping Bai; Alicja Bielawska; James S Norris; Sakamuri V Reddy; Yusuf A Hannun; Azizul Haque
Journal:  Cytokine       Date:  2020-07-29       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.